High variability of peptidylarginine deiminase 4 (PADI4) in a healthy white population: characterization of six new variants of PADI4 exons 2–4 by a novel haplotype-specific sequencing-based approach

Author： Hoppe Berthold   Heymann Guido   Tolou Farzaneh   Kiesewetter Holger   Doerner Thomas   Salama Abdulgabar  

Publisher： Springer Publishing Company

ISSN： 0946-2716

Source： Journal of Molecular Medicine, Vol.82, Iss.11, 2004-11, pp. : 762-767

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The W620 Polymorphism in PTPN22 Disrupts Its Interaction With Peptidylarginine Deiminase Type 4 and Enhances Citrullination and NETosis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 9, 2015-09 ,pp. : 2323-2334

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insights Into the Significance of Peptidylarginine Deiminase 4 and Antibodies Against Citrullinated Antigens in the Absence of “True ACPAs” in an Experimental Model of Arthritis: Comment on the Article by Shelef et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 9, 2014-09 ,pp. : 2642-2644

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterization of the novel HLA‐B*48:43 allele by sequencing‐based typing

By  

HLA, Vol. 91, Iss. 2, 2018-02 ,pp. : 139-140

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of PADI4 in patients with ankylosing spondylitis and its role in mediating the effects of TNF-α on the proliferation and osteogenic differentiation of human mesenchymal stem cells

By    

International Journal of Molecular Medicine, Vol. 36, Iss. 2, 2015-01 ,pp. : 565-570

Spandidos Publications

Access to resources Recommend Favorite

Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 182, Iss. 2, 2015-11 ,pp. : 119-131

John Wiley & Sons Inc

Access to resources Recommend Favorite